A22-301

Clinical Trial Grant

Duke Scholars

Principal Investigator Lindsay Anne Magura Rein Medicine, Hematologic Malignancies and Cellular Therapy

Awarded By

PharmaEssentia USA Corporation

Start Date

July 17, 2023

End Date

July 14, 2028

Awarded By

PharmaEssentia USA Corporation

Start Date

July 17, 2023

End Date

July 14, 2028